Five new SEC Form D filings hit EDGAR this week, together raising $771.8M. Here's the roundup, scored for B2B sales relevance by Funding Signals.
Oxide Computer Co — $445.0M
Score: 93/100. Other Technology. Filed 2026-08-04. The largest raise on this list by a wide margin.
Jasper Therapeutics, Inc. — $132.0M
Score: 93/100. Biotechnology.
Emerald AI, Inc. — $90.2M
Score: 92/100. Other Technology.
Integrated Biosciences, Inc. — $68.4M
Score: 93/100. Biotechnology.
Theradaptive, Inc. — $36.2M
Score: 91/100. Biotechnology.
Why this matters for sales teams
Each of these companies just got a large budget injection and hasn't been pitched by every vendor in the space yet. That window closes fast — usually within a few weeks of the raise becoming public knowledge.
Most teams find out about raises like this from a TechCrunch writeup two or three weeks after the SEC filing was already public record. By then, several other vendors have already reached out.
Funding Signals scores every SEC Form D filing the moment it hits EDGAR, ranked by likelihood-to-buy-soon, so you're not finding out last.
Free API key, no card required: https://fundingsignals.net/?utm_source=devto&utm_medium=article&utm_campaign=round15
